Clinical Trials List
2019-01-01 - 2023-09-30
Phase I
Recruiting2
Terminated4
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- Wen-Fang Cheng Division of Obstetrics & Gynecology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- TA-CHEN HUANG Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- Ying-Chun Shen 無
- Chong-Jen Yu Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- Wei-Wu Chen Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 呂理駿 無
- James Chih-Hsin Yang Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 張端瑩 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- TSUNG-HAO LIU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU 無
- Cheng-Kuang Yang 無
- 李權醫師 無
- 陳建志醫師 無
- 謝合原醫師 無
- 石宇軒醫師 無
- Chih-Chiang Hung 無
- 鄭皓升醫師 無
- CHENG-HSIEN LIN 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳敬炫醫師 無
- Ta-Chih Liu 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chen-Yuan Lin 無
- Su-Peng Yeh 無
- Che-Hung Lin 無
- Chi-Ching Chen 無
- Li-Yuan Bai 無
- Ming-Yu Lien 無
- 鄭富銘 無
- 王秀慈 無
- Chang-Fang Chiu 無
- Yu-Min Liao 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
75 participants
-
Global
412 participants